Cargando…
Crystal structures of sampatrilat and sampatrilat‐Asp in complex with human ACE – a molecular basis for domain selectivity
Angiotensin‐1‐converting enzyme (ACE) is a zinc metallopeptidase that consists of two homologous catalytic domains (known as nACE and cACE) with different substrate specificities. Based on kinetic studies it was previously reported that sampatrilat, a tight‐binding inhibitor of ACE, K (i) = 13.8 nm...
Autores principales: | Cozier, Gyles E., Schwager, Sylva L., Sharma, Rajni K., Chibale, Kelly, Sturrock, Edward D., Acharya, K. Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947662/ https://www.ncbi.nlm.nih.gov/pubmed/29476645 http://dx.doi.org/10.1111/febs.14421 |
Ejemplares similares
-
Molecular Basis
for Omapatrilat and Sampatrilat Binding
to Neprilysin—Implications for Dual Inhibitor Design with Angiotensin-Converting
Enzyme
por: Sharma, Urvashi, et al.
Publicado: (2020) -
ACE-domain selectivity extends beyond direct interacting residues at the active site
por: Cozier, Gyles E., et al.
Publicado: (2020) -
Structural basis for the inhibition of human angiotensin‐1 converting enzyme by fosinoprilat
por: Cozier, Gyles E., et al.
Publicado: (2022) -
ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV
por: Lubbe, Lizelle, et al.
Publicado: (2020) -
Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
por: Masuyer, Geoffrey, et al.
Publicado: (2012)